Seth P. Lerner

Advisor at Nucleix

Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Vice-Chair for Faculty Affairs. His research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, surgical quality and outcomes and integrated genomic characterization of bladder cancer. He has 27 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is chair of the Local Bladder Cancer committee of SWOG, co-chair of the GU Steering Committee for CTEP and co-chaired the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Nucleix

Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products for various cancer types.


Industries

Headquarters

Na'an, Israel

Employees

51-200

Links